Dr. Reddy’s posts audio of March-quarter 2026 earnings call for investors
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Dr Reddy’s Laboratories ( (RDY) ) is now available.
Dr. Reddy’s Laboratories has notified stock exchanges that it has made available an audio recording of its earnings call for the quarter ended March 31, 2026, which was conducted on May 12, 2026. The disclosure, made under India’s listing obligations framework and shared with the National Stock Exchange, BSE, NYSE and NSE IFSC, underscores the company’s adherence to transparency and timely communication with investors by providing access to its latest quarterly discussion in audio format.
The most recent analyst rating on (RDY) stock is a Buy with a $16.90 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
The score is driven primarily by strong fundamentals (profitability, growth, and low leverage), tempered by weaker cash-flow conversion. Earnings-call takeaways are moderately positive due to pipeline progress and strong liquidity, but near-term margins and regulatory delays add risk. Technicals are neutral-to-soft and valuation is reasonable with a low dividend yield.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is an India-based pharmaceutical company focused on generic medicines, active pharmaceutical ingredients and biosimilars for global markets, with shares listed in India and on the New York Stock Exchange. The company serves regulated markets including India, the U.S. and other international geographies, and is subject to Indian securities and listing regulations.
Average Trading Volume: 2,375,381
Technical Sentiment Signal: Hold
Current Market Cap: $11.29B
See more data about RDY stock on TipRanks’ Stock Analysis page.
